Gohal Gassem, Moni Sivakumar S, Bakkari Mohammed Ali, Elmobark Mohamed Eltaib
Department of Pediatrics, Faculty of Medicine, Jazan University, Jazan 45142, Saudi Arabia.
Health Research Centre, Jazan University, Jazan 45142, Saudi Arabia.
J Clin Med. 2024 Sep 27;13(19):5775. doi: 10.3390/jcm13195775.
Asthma, a complex disease characterized by persistent airway inflammation, remains an urgent global health concern. We explored the critical role of allergic biomarkers and dysregulated immune system in asthma through an extensive literature review in databases such as Web of Science, PubMed, EMBASE, Scopus, and Google Scholar. This review summarizes the growing data on the pivotal role of allergic biomarkers and dysregulated immune system in the development and evolution of asthma. Recent studies have uncovered several biomarkers that elucidate intrinsic allergic mechanisms in individuals with asthma. This article highlights these biomarkers' potential in predicting asthma onset, assessing its intensity, guiding therapeutic interventions, and tracking disease progression. We also explore the innovative therapeutic prospects arising from the convergence of allergy and dysregulated immune system in asthma and emphasize the potential for precision medicine approaches. Understanding allergic biomarkers intertwined with a dysregulated immune system heralds a new era in asthma treatment and points to improved and individualized treatment modalities.
哮喘是一种以持续性气道炎症为特征的复杂疾病,仍然是全球紧迫的健康问题。我们通过在科学网、PubMed、EMBASE、Scopus和谷歌学术等数据库中进行广泛的文献综述,探讨了过敏生物标志物和免疫系统失调在哮喘中的关键作用。本综述总结了关于过敏生物标志物和免疫系统失调在哮喘发生和发展中的关键作用的越来越多的数据。最近的研究发现了几种生物标志物,这些生物标志物阐明了哮喘患者的内在过敏机制。本文强调了这些生物标志物在预测哮喘发作、评估其严重程度、指导治疗干预和跟踪疾病进展方面的潜力。我们还探讨了哮喘中过敏与免疫系统失调相结合所带来的创新治疗前景,并强调了精准医学方法的潜力。了解与免疫系统失调交织在一起的过敏生物标志物预示着哮喘治疗的新时代,并指向改进和个性化的治疗模式。